Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.21 - $1.68 $770,649 - $1.07 Million
636,900 Added 121.22%
1,162,300 $1.73 Million
Q2 2024

Aug 14, 2024

BUY
$1.21 - $1.42 $589,028 - $691,256
486,800 Added 1261.14%
525,400 $656,000
Q1 2024

May 15, 2024

SELL
$0.87 - $1.57 $82,476 - $148,836
-94,800 Reduced 71.06%
38,600 $46,000
Q4 2023

Feb 14, 2024

BUY
$1.23 - $1.63 $94,587 - $125,346
76,900 Added 136.11%
133,400 $201,000
Q3 2023

Nov 14, 2023

BUY
$1.5 - $2.17 $4,050 - $5,859
2,700 Added 5.02%
56,500 $90,000
Q2 2023

Aug 14, 2023

SELL
$1.37 - $2.17 $1,096 - $1,736
-800 Reduced 1.47%
53,800 $116,000
Q1 2023

May 15, 2023

SELL
$1.06 - $1.61 $104,728 - $159,068
-98,800 Reduced 64.41%
54,600 $79,000
Q4 2022

Feb 14, 2023

SELL
$1.05 - $2.01 $40,740 - $77,987
-38,800 Reduced 20.19%
153,400 $191,000
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.81 $103,351 - $160,451
-57,100 Reduced 22.9%
192,200 $363,000

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.24B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.